Xian Ming

SEC source: 0001628280-26-038972 · wk-form4_1780011076.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,822.918

Underlying: Common Stock · 11,680 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on May 26, 2027. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock on the date of vesting.

F1 · derivative.exercise_date: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on May 26, 2027. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock on the date of vesting.

F1 · derivative.expiration_date: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on May 26, 2027. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock on the date of vesting.

SEC source: 0001628280-25-033187 · wk-form4_1750979198.xml · derivative · entry 2

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,142.918

Underlying: Common Stock · 6,013.35 shares

Expires not disclosed

F2 · derivative.exercise_price: The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Plan.

F3 · price: The price per share of $13.39 is based on the 20-day moving average price of the Issuer's common stock as of June 6, 2025.

F2 · derivative.exercise_date: The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Plan.

F2 · derivative.expiration_date: The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Plan.

SEC source: 0001628280-25-033187 · wk-form4_1750979198.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,129.568

Underlying: Common Stock · 11,167.65 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the contingent right to receive shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"). These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Plan.

F1 · derivative.exercise_date: Represents the contingent right to receive shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"). These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Plan.

F1 · derivative.expiration_date: Represents the contingent right to receive shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"). These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Plan.

SEC source: 0001628280-24-029656 · wk-form4_1719265644.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,961.918

Underlying: Common Stock · 10,149 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the contingent right to receive 10,149 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

F1 · derivative.exercise_date: Represents the contingent right to receive 10,149 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

F1 · derivative.expiration_date: Represents the contingent right to receive 10,149 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

SEC source: 0001628280-23-038374 · wk-form4_1699579144.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,812.918

Underlying: Common Stock · 48.441 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F2 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

F1 · derivative.exercise_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F1 · derivative.expiration_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

SEC source: 0001628280-23-028939 · wk-form4_1691703313.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,764.477

Underlying: Common Stock · 36.643 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F2 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

F1 · derivative.exercise_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F1 · derivative.expiration_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

SEC source: 0001628280-23-022810 · wk-form4_1687307849.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,727.834

Underlying: Common Stock · 2,742 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the contingent right to receive 2,742 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

F1 · derivative.exercise_date: Represents the contingent right to receive 2,742 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

F1 · derivative.expiration_date: Represents the contingent right to receive 2,742 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

SEC source: 0001628280-23-017662 · wf-form4_168384125726827.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,985.834

Underlying: Common Stock · 12.379 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F2 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

F1 · derivative.exercise_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F1 · derivative.expiration_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

SEC source: 0001628280-23-003055 · wf-form4_167599477045468.xml · derivative · entry 2

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,973.454

Underlying: Common Stock · 9.232 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F2 · kind: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

F1 · derivative.exercise_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F1 · derivative.expiration_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

SEC source: 0001628280-23-003055 · wf-form4_167599477045468.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,964.222

Underlying: Common Stock · 9.7766 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F2 · kind: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

F1 · derivative.exercise_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F1 · derivative.expiration_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

SEC source: 0001104659-22-088740 · tm2223137-5_4seq1.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,954.445

Underlying: Common Stock · 7.445 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F2 · kind: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

F1 · derivative.exercise_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F1 · derivative.expiration_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

SEC source: 0001104659-22-073172 · tm2219043-6_4seq1.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,947

Underlying: Common Stock · 1,317 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the contingent right to receive 1,317 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 16, 2023. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

F1 · derivative.exercise_date: Represents the contingent right to receive 1,317 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 16, 2023. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

F1 · derivative.expiration_date: Represents the contingent right to receive 1,317 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 16, 2023. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

F2 · balance_after: Mr. Xian's beneficial ownership consists of 1,317 and 630 restricted stock units granted June 16, 2022 and June 3, 2021, respectively, all of which are deferred pursuant to the terms of the Deferred Compensation Plan. Prior grants of restricted stock units for Mr. Xian were settled in cash on their respective vesting dates.

SEC source: 0001104659-21-077873 · tm2119051-7_4seq1.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,751

Underlying: Common Stock · 630 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the right to receive 630 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock.

F1 · derivative.exercise_date: Represents the right to receive 630 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock.

F1 · derivative.expiration_date: Represents the right to receive 630 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock.

SEC source: 0001104659-20-081283 · tm2024193d3_4.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,121

Underlying: Common Stock · 1,083 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2021. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock on the date of vesting.

F1 · derivative.exercise_date: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2021. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock on the date of vesting.

F1 · derivative.expiration_date: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2021. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock on the date of vesting.

SEC source: 0001144204-19-010330 · tv514849_form4.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,038

Underlying: Common Stock · 1,038 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2020. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock on the date of vesting.

F1 · derivative.exercise_date: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2020. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock on the date of vesting.

F1 · derivative.expiration_date: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2020. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock on the date of vesting.